Lunit AI software receives licensing from Health Canada
Canadian medical device regulator Health Canada issued class II medical licenses for Lunit’s Insight CXR AI software for chest x-rays and Insight MMG AI application for mammography. Designed to detect suspicious lesions in chest x-ray images, Insight CXR can detect 10 of the most common chest abnormalities, including support for tuberculosis screening, with 97% to 99% accuracy, according to the vendor.
Meanwhile, Insight MMG offers 96% accuracy in analyzing mammography images and has been shown to reduce the chances of undetected breast cancer cases by 50% in mammogram screenings, the…
Go to publisher site for the complete article: